- Report
- October 2023
- 178 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Clinical Trials
- July 2022
- 60 Pages
Global
From €1565EUR$1,575USD£1,301GBP
€2235EUR$2,250USD£1,859GBP
- Report
- July 2022
- 100 Pages
Global
From €1912EUR$1,925USD£1,590GBP
€2732EUR$2,750USD£2,272GBP
- Report
- January 2022
- 200 Pages
Global
From €5216EUR$5,250USD£4,337GBP
€7451EUR$7,500USD£6,195GBP
- Report
- December 2023
- 114 Pages
From €2469EUR$2,485USD£2,053GBP
€3527EUR$3,550USD£2,932GBP
From €2086EUR$2,100USD£1,735GBP
€2980EUR$3,000USD£2,478GBP
- Report
- July 2023
- 145 Pages
From €2086EUR$2,100USD£1,735GBP
€2980EUR$3,000USD£2,478GBP
- Report
- July 2023
- 144 Pages
North America
From €2086EUR$2,100USD£1,735GBP
€2980EUR$3,000USD£2,478GBP
- Report
- July 2023
- 106 Pages
Africa, Middle East
From €2086EUR$2,100USD£1,735GBP
€2980EUR$3,000USD£2,478GBP
- Report
- July 2023
- 118 Pages
Europe
From €2086EUR$2,100USD£1,735GBP
€2980EUR$3,000USD£2,478GBP
- Report
- June 2023
- 122 Pages
Asia Pacific
From €2086EUR$2,100USD£1,735GBP
€2980EUR$3,000USD£2,478GBP
- Report
- March 2023
- 236 Pages
Global
From €3164EUR$3,185USD£2,631GBP
€4520EUR$4,550USD£3,758GBP
- Report
- January 2023
- 112 Pages
From €2086EUR$2,100USD£1,735GBP
€2980EUR$3,000USD£2,478GBP
- Report
- January 2023
- 115 Pages
North America
From €2086EUR$2,100USD£1,735GBP
€2980EUR$3,000USD£2,478GBP
- Report
- January 2023
- 285 Pages
Global
From €3164EUR$3,185USD£2,631GBP
€4520EUR$4,550USD£3,758GBP
- Report
- December 2022
- 112 Pages
From €2086EUR$2,100USD£1,735GBP
€2980EUR$3,000USD£2,478GBP
- Report
- December 2022
- 122 Pages
North America
From €2086EUR$2,100USD£1,735GBP
€2980EUR$3,000USD£2,478GBP
- Report
- December 2022
- 118 Pages
Middle East, Africa
From €2086EUR$2,100USD£1,735GBP
€2980EUR$3,000USD£2,478GBP
- Report
- December 2022
- 137 Pages
Europe
From €2086EUR$2,100USD£1,735GBP
€2980EUR$3,000USD£2,478GBP
- Report
- December 2022
- 139 Pages
Asia Pacific
From €2086EUR$2,100USD£1,735GBP
€2980EUR$3,000USD£2,478GBP
The Respiratory Devices market is a segment of the medical device industry that focuses on the development and production of devices used to diagnose, treat, and monitor respiratory conditions. These devices include ventilators, oxygen concentrators, nebulizers, and CPAP machines. Ventilators are used to assist with breathing in patients with severe respiratory conditions, while oxygen concentrators are used to provide supplemental oxygen to those with low oxygen levels. Nebulizers are used to deliver medication to the lungs, and CPAP machines are used to treat sleep apnea.
Some of the major players in the Respiratory Devices market include Philips, ResMed, Fisher & Paykel, Drägerwerk, and GE Healthcare. These companies are involved in the development and production of a wide range of respiratory devices, from basic oxygen concentrators to sophisticated ventilators. Show Less Read more